Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig A Erickson

Showing results (51-60 of 158) with videos related to

Pageof 16
Sort By:
Frontiers in Neuroscience|September 6, 2017
Diagnosing Autism Spectrum Disorder from Brain Resting-State Functional Connectivity Patterns Using a Deep Neural Network with a Novel Feature Selection MethodXinyu Guo, Kelli C Dominick, Ali A Minai, et al.
Journal of Child and Adolescent Psychopharmacology|February 3, 2018
Risperidone Treatment for Irritability in Fragile X SyndromeKelli C Dominick, Logan K Wink, Ernest V Pedapati, et al.
Psychopharmacology|October 4, 2006
A retrospective study of memantine in children and adolescents with pervasive developmental disordersCraig A Erickson, David J Posey, Kimberly A Stigler, et al.
Journal of Autism and Developmental Disorders|October 23, 2025
Brief Report: Differences Between Stanford-Binet Abbreviated and Full-Scale Estimates of IQ in Fragile X Syndrome Vary Across DevelopmentWalker S McKinney, Meredith Nelson, Rebecca C Shaffer, et al.
Journal of Child and Adolescent Psychopharmacology|February 26, 2014
Body mass index change in autism spectrum disorders: comparison of treatment with risperidone and aripiprazoleLogan K Wink, Maureen Early, Tori Schaefer, et al.
Journal of Child and Adolescent Psychopharmacology|December 6, 2011
An open-label naturalistic pilot study of acamprosate in youth with autistic disorderCraig A Erickson, Maureen Early, Kimberly A Stigler, et al.
American Journal of Medical Genetics. Part A|August 29, 2023
Genetic syndromes are prevalent in patients with comorbid neurodevelopmental disorders and catatoniaAmelle Shillington, Katherine J Zappia, Lori White, et al.
Frontiers in Psychiatry|October 6, 2025
Beyond the Fragile X protein: neighborhood characteristics explain individual differences in IQ and adaptive behaviors of Fragile X syndromeWalker S McKinney, Austin Corsmeier, Ashley Dapore, et al.
Journal of Autism and Developmental Disorders|November 4, 2005
Gastrointestinal factors in autistic disorder: a critical reviewCraig A Erickson, Kimberly A Stigler, Mark R Corkins, et al.
Frontiers in Psychiatry|February 6, 2023
Editorial: Precision medicine approaches for heterogeneous conditions such as autism spectrum disorders (The need for a biomarker exploration phase in clinical trials - Phase 2m)David Q Beversdorf, Evdokia Anagnostou, Antonio Hardan, et al.
Pageof 16

Showing results (51-60 of 158) with videos related to

Sort By:
Pageof 16
Frontiers in Neuroscience|September 6, 2017
Diagnosing Autism Spectrum Disorder from Brain Resting-State Functional Connectivity Patterns Using a Deep Neural Network with a Novel Feature Selection MethodXinyu Guo, Kelli C Dominick, Ali A Minai, et al.
Journal of Child and Adolescent Psychopharmacology|February 3, 2018
Risperidone Treatment for Irritability in Fragile X SyndromeKelli C Dominick, Logan K Wink, Ernest V Pedapati, et al.
Psychopharmacology|October 4, 2006
A retrospective study of memantine in children and adolescents with pervasive developmental disordersCraig A Erickson, David J Posey, Kimberly A Stigler, et al.
Journal of Autism and Developmental Disorders|October 23, 2025
Brief Report: Differences Between Stanford-Binet Abbreviated and Full-Scale Estimates of IQ in Fragile X Syndrome Vary Across DevelopmentWalker S McKinney, Meredith Nelson, Rebecca C Shaffer, et al.
Journal of Child and Adolescent Psychopharmacology|February 26, 2014
Body mass index change in autism spectrum disorders: comparison of treatment with risperidone and aripiprazoleLogan K Wink, Maureen Early, Tori Schaefer, et al.
Journal of Child and Adolescent Psychopharmacology|December 6, 2011
An open-label naturalistic pilot study of acamprosate in youth with autistic disorderCraig A Erickson, Maureen Early, Kimberly A Stigler, et al.
American Journal of Medical Genetics. Part A|August 29, 2023
Genetic syndromes are prevalent in patients with comorbid neurodevelopmental disorders and catatoniaAmelle Shillington, Katherine J Zappia, Lori White, et al.
Frontiers in Psychiatry|October 6, 2025
Beyond the Fragile X protein: neighborhood characteristics explain individual differences in IQ and adaptive behaviors of Fragile X syndromeWalker S McKinney, Austin Corsmeier, Ashley Dapore, et al.
Journal of Autism and Developmental Disorders|November 4, 2005
Gastrointestinal factors in autistic disorder: a critical reviewCraig A Erickson, Kimberly A Stigler, Mark R Corkins, et al.
Frontiers in Psychiatry|February 6, 2023
Editorial: Precision medicine approaches for heterogeneous conditions such as autism spectrum disorders (The need for a biomarker exploration phase in clinical trials - Phase 2m)David Q Beversdorf, Evdokia Anagnostou, Antonio Hardan, et al.
Pageof 16